Contact

All Stories

  1. Admission due to heart failure and pulmonary function testing: is there a COPD?

    Article • September 2021, European Respiratory Society (ERS)

    Nataliia Slepchenko

  2. Is there a role of Heart Failure in pulmonary function testing?

    Article • September 2021, European Respiratory Society (ERS)

    Nataliia Slepchenko

  3. Efficacy of instant messages applications in smoking cessation in patients with COPD

    Article • September 2021, European Respiratory Society (ERS)

    Nataliia Slepchenko

  4. Features of the COPD course in patients with different alleles of C79G (rs1072714) of ADRB2 gene

    Article • Biomedical and Biosocial Anthropology, March 2021, Vinnytsia National Pyrogov Memorial Medical University

    Nataliia Slepchenko

  5. EFFECT OF COMBINATION OF TIOTROPIUM/ OLODATEROL ON PULMONARY FUNCTION IN PATIENTS WITH COPD IN THE REAL CLINICAL PRACTICE

    Article • Ukrainian Pulmonology Journal, January 2021, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  6. PECULIARITIES OF THE COURSE OF COPD IN PATIENTS WITH DIFFERENT A46G (RS1042713) ALLELES OF ADRB2 GENE

    Article • Ukrainian Pulmonology Journal, January 2021, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  7. ASTHMA AND SMOKING

    Article • Ukrainian Pulmonology Journal, January 2021, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  8. Can reversibility determine clinical course in patients with COPD?

    Article • September 2020, European Respiratory Society (ERS)

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  9. “Smoking” vs “non-smoking” COPD: how dramatic is the difference?

    Article • September 2020, European Respiratory Society (ERS)

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  10. Do technologies make a difference in adherence to treatment: instant messaging application use?

    Article • September 2020, European Respiratory Society (ERS)

    Nataliia Slepchenko

  11. Budesonide/formoterol efficacy in “obese” asthma

    Article • September 2020, European Respiratory Society (ERS)

    Nataliia Slepchenko

  12. Does heart failure make a difference in pulmonary function testing?

    Article • September 2020, European Respiratory Society (ERS)

    Nataliia Slepchenko

  13. COPD exacerbations and adherence to treatment improvement:what goal can be achieved?

    Article • September 2020, European Respiratory Society (ERS)

    Nataliia Slepchenko

  14. Spirometry parameters and adherence to COPD treatment: is there association?

    Article • September 2020, European Respiratory Society (ERS)

    Nataliia Slepchenko

  15. INFLUENCE OF BASIC COMBINED BRONCHOLYTIC THERAPY ON THE COURSE OF COPD: RESULTS OF INTERNATIONAL RESEARCH AND REGIONAL SUBANALYSIS

    Article • Ukrainian Pulmonology Journal, January 2020, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  16. CLINICO-FUNCTIONAL ASSESSMENT OF COPD COURSE IN PATIENT WITH DIFFERENT REVERSIBILITY OF BRONCHIAL OBSTRUCTION

    Article • Asthma and allergy, January 2020, Asthma and Allergy

    Nataliia Slepchenko

  17. PULMONARY EMBOLISM AND PULMONARY DISEASES. KEY STATEMENTS OF 2019 ERS/ESC GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF ACUTE PULMONARY EMBOLISM

    Article • Ukrainian Pulmonology Journal, January 2020, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  18. Immediate effects of smoking: does tobacco and electronic cigarettes differ?

    Article • September 2019, European Respiratory Society (ERS)

    Nataliia Slepchenko, Dr Kostiantyn Dmytriiev

  19. Budesoinde/formoterol: does eosinophil count cause different outcomes?

    Article • September 2019, European Respiratory Society (ERS)

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  20. ADHERENCE TO COPD TREATMENT: IS IT REALLY OF CRUCIAL IMPORTANCE?

    Article • Asthma and allergy, January 2019, Asthma and Allergy

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  21. ASTHMA AND THE HEART

    Article • Ukrainian Pulmonology Journal, January 2019, Ukrainian Pulmonary Journal

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  22. MODERN APPROACHES TO THE INHALATION THERAPY IN PULMONARY BRONCHOOBSTRUCTIVE PATHOLOGY

    Article • Asthma and allergy, January 2019, Asthma and Allergy

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  23. INSUFFICIENT ADHERENCE TO COPD BASIS THERAPY: WHAT FACTORS ARE DETERMINING?

    Article • Asthma and allergy, January 2019, Asthma and Allergy

    Nataliia Slepchenko

  24. ROLE OF E-CIGARETTES IN THE SMOKING CESSATION

    Article • September 2018, European Respiratory Society (ERS)

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  25. ADHERENCE TO TREATMENT: METHODS OF ITS IMPROVEMENT IN THE INHALATION THERAPY OF BRONCHIAL ASTHMA

    Article • Ukrainian Pulmonology Journal, January 2018, Ukrainian Pulmonary Journal

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  26. CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THE HEART: ACHIEVMENTS AND CURRENT QUESTIONS

    Article • Ukrainian Pulmonology Journal, January 2018, Ukrainian Pulmonary Journal

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  27. INFLUENCE OF GENETIC FACTORS ON THE DEVELOPMENT AND COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    Article • Ukrainian Pulmonology Journal, January 2018, Ukrainian Pulmonary Journal

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  28. Budesonid/formoterol easyhaler: clinical efficiency and adherence to treatment in patients with partly controlled bronchial asthma (BA)

    Article • September 2017, European Respiratory Society (ERS)

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  29. Author Index

    Article • European Heart Journal, September 2014, European Society of Cardiology

    Nataliia Slepchenko